QTTB · NASDAQ
Q32 Bio (QTTB) Stock Price & Fundamentals
Q32 Bio (QTTB) closed at $840.43 on Oct 9, 2026, down 0.70% from the previous close of $846.34.
Share price, past year
1Y +35.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $840.43 |
| Sep 30, 2026 | $791.55 |
| Aug 31, 2026 | $781.97 |
| Jul 31, 2026 | $779.88 |
| Jun 30, 2026 | $715.84 |
| May 29, 2026 | $720.86 |
| Apr 30, 2026 | $747.62 |
| Mar 31, 2026 | $761.58 |
| Feb 27, 2026 | $754.52 |
| Jan 30, 2026 | $763.71 |
| Dec 31, 2025 | $724.52 |
| Nov 28, 2025 | $691.95 |
| Oct 31, 2025 | $656.27 |
Key statistics
- Market cap
- $19.95B
- P/E (TTM)
- 269.4
- EPS (TTM)
- $3.12
- Revenue (TTM)
- —
- Net income (TTM)
- $33.79M
- Shares outstanding
- 23.7M
- Dividend yield
- —
- 52-week range
- $619.32 – $846.34
Q32 Bio's market cap is $19.95B, based on a share price of $840.43 and 23.7M shares outstanding as of Jun 30, 2026.
Financials
Q32 Bio reported revenue of $53.74M for fiscal 2025.
Q32 Bio earned net income of $29.82M in fiscal 2025, a net margin of 55.5%.
Fiscal 2025 revenue was the highest in the 8 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $53.74M | — | $29.82M | 55.5% | $2.42 | −$33.54M |
| FY2024ended Dec 31, 2024 | $0.00 | +100.0% | −$47.73M | — | −$6.58 | −$67.79M |
| FY2023ended Dec 31, 2023 | −$6.65M | −307.3% | −$53.74M | 808.0% | −$153.96 | −$18.68M |
| FY2022ended Dec 31, 2022 | $3.21M | −90.6% | −$5.01M | −156.0% | −$0.09 | −$114.95M |
| FY2021ended Dec 31, 2021 | $33.97M | +1,157.3% | −$95.76M | −281.9% | −$1.73 | −$112.15M |
| FY2020ended Dec 31, 2020 | $2.70M | +62.2% | −$128.69M | −4,762.9% | −$2.80 | −$98.07M |
| FY2019ended Dec 31, 2019 | $1.67M | −54.8% | −$103.92M | −6,237.5% | −$2.47 | −$113.19M |
| FY2018ended Dec 31, 2018 | $3.68M | — | −$55.58M | −1,508.6% | −$1.95 | −$67.50M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2024ended Dec 31, 2024 | $0.00 | −$14.19M | $2.63 |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$17.60M | −$1.46 |
| Q2 FY2024ended Jun 30, 2024 | $0.00 | — | — |
| Q1 FY2024ended Mar 31, 2024 | $0.00 | — | — |
| Q3 FY2023ended Sep 30, 2023 | $1.86M | — | — |
| Q2 FY2023ended Jun 30, 2023 | $3.21M | — | — |
| Q1 FY2023ended Mar 31, 2023 | $2.95M | — | — |
| Q4 FY2022ended Dec 31, 2022 | $802.00K | — | — |
Company profile
- Name
- Q32 Bio Inc.
- Ticker
- QTTB
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 830 Winter Street, Waltham, MA 02451
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001661998
Recent SEC filings
- Sep 30, 2026
- Sep 14, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jul 15, 2026
- Jul 13, 2026
- Jul 13, 2026
- Jun 16, 2026
Frequently asked questions
What is Q32 Bio's stock price?
Q32 Bio (QTTB) closed at $840.43 on Oct 9, 2026, down 0.70% from the previous close of $846.34.
What is Q32 Bio's market cap?
Q32 Bio's market cap is $19.95B, based on a share price of $840.43 and 23.7M shares outstanding as of Jun 30, 2026.
How much revenue does Q32 Bio make?
Q32 Bio reported revenue of $53.74M for fiscal 2025.
What is QTTB's P/E ratio?
Q32 Bio's price-to-earnings ratio is 269.4, based on trailing twelve-month diluted EPS of $3.12.
Does Q32 Bio pay a dividend?
Q32 Bio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Q32 Bio Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures